Financial Advantage, Inc. Merck & Co., Inc. Transaction History

Financial Advantage, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $71,451 - $80,092	972 Added 3471.43%	1,000 $82,000
Q3 2020 Oct 27, 2020	SELL	$73.18 - $82.95 $5,781 - $6,553	-79 Reduced 73.83%	28 $2,000
Q4 2019 Jan 31, 2020	SELL	$77.58 - $87.54 $9,775 - $11,030	-126 Reduced 54.08%	107 $9,000
Q1 2019 Apr 17, 2019	SELL	$69.58 - $79.36 $3.74 Million - $4.26 Million	-53,686 Reduced 99.57%	233 $19,000
Q4 2018 Jan 30, 2019	SELL	$65.24 - $75.71 $48,734 - $56,555	-747 Reduced 1.37%	53,919 $4.12 Million
Q3 2018 Oct 31, 2018	BUY	$57.69 - $67.84 $38,652 - $45,452	670 Added 1.24%	54,666 $3.88 Million
Q2 2018 Jul 30, 2018	SELL	$50.83 - $59.72 $27,244 - $32,009	-536 Reduced 0.98%	53,996 $3.28 Million
Q1 2018 May 10, 2018	BUY	$50.96 - $59.23 $9,325 - $10,839	183 Added 0.34%	54,532 $2.97 Million
Q4 2017 Feb 07, 2018	BUY	$51.62 - $61.64 $12,388 - $14,793	240 Added 0.44%	54,349 $3.06 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $60,664 - $65,276	1,034 Added 1.95%	54,109 $3.47 Million
Q2 2017 Aug 11, 2017	BUY	N/A	53,075	53,075 $3.4 Million

3,819

1.87B

15.6M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $250B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Financial Advantage, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Advantage, Inc. with notifications on news.